INS and type 1 diabetes mellitus: Insulin replacement, the only approved therapy for the treatment of type 1 diabetes (T1D), treats the symptoms but not the underlying cause of the disease, namely, immune-mediated destruction of the insulin-producing β cells of the pancreas.